Xin Lang Cai Jing·2026-02-25 12:43Core Viewpoint - Hainan Haiyao announced that it received a letter from its controlling shareholders, Xinxing Jihua Group Co., Ltd. and Xinxing Jihua Pharmaceutical Holdings Co., Ltd., regarding the extension of the commitment period to resolve competition issues with Xinxing Lingyun Pharmaceutical Chemical Co., Ltd. and Tianjin Huajin Pharmaceutical Co., Ltd. [1] Group 1 - The original commitment to resolve the competition issues was set to expire on February 24, 2025, but has now been extended by two years [1] - The controlling shareholders had previously committed to resolving the competition issues within one year from the original deadline [1] - The extension is attributed to historical legacy issues, profitability concerns, and the complexity of audit evaluations and related procedures [1]